Sign in
Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2024
Pediatric Cases That All Retina Surgeons Will Encounter
Audina M. Berrocal, MD FASRS
Yoshihiro Yonekawa, MD, FASRS
Philip J. Ferrone, MD, FASRS
Caroline Baumal, MD
Lejla Vajzovic, MD, FASRS
Emmanuel Chang, MD PhD FACS FASRS
Webinars and Journal Clubs
2022
ADVM-022 Intravitreal Gene Therapy for Neovascular AMD: Phase 1 OPTIC Trial Update
Dante Joseph Pieramici, MD
Annual Meeting Talks
Category: Retinal Vascular Disease